The antibody hinders uPA binding to the cell surface of MCF-7 and MCF-10A neoT breast cells [13], resulting in lower plasmin generation, adhesion, invasiveness and G1/S transition of breast tumor cells. The gene discussed is PLAU; the disease is breast neoplasm.